Trial Profile
Immunogenicity and tolerability of an AdVac-based tuberculosis vaccine in BCG-naive subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Nov 2007
Price :
$35
*
At a glance
- Drugs Tuberculosis vaccine (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Aeras; Crucell
- 13 Nov 2007 Results are expected in the first quarter of 2008.
- 31 Oct 2006 New trial record.